BDBM261495 US10011568, Ex. No. 19::US9708266, 19

SMILES CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1c(CO)nc(cc1-c1ccc(F)cc1C)C1CCC(CC(O)=O)CC1

InChI Key InChIKey=AOCBCZSDWBMPHN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 261495   

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261495(US9708266, 19 | US10011568, Ex. No. 19)
Affinity DataIC50: 4.96nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261495(US9708266, 19 | US10011568, Ex. No. 19)
Affinity DataIC50: 4.96nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent